- Filed
- Jun 16, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jun 16, 2025 | 10.67M sh |
| Capex | Q2 2025 · Apr 30, 2025 | $34K |
| Capex | Q2 2025 · Apr 30, 2024 | $169K |
| Capex | Q2 2025 · Apr 30, 2024 | $312K |
| Cash And Equivalents | Q2 2025 · Apr 30, 2025 | $3.59M |
| Cash And Equivalents | Q2 2025 · Oct 31, 2024 | $839K |
| Current Liabilities | Q2 2025 · Apr 30, 2025 | $20.6M |
| Current Liabilities | Q2 2025 · Oct 31, 2024 | $18.09M |
| Total Liabilities | Q2 2025 · Apr 30, 2025 | $38.51M |
| Total Liabilities | Q2 2025 · Oct 31, 2024 | $36.98M |
| Current Assets | Q2 2025 · Apr 30, 2025 | $32.72M |
| Current Assets | Q2 2025 · Oct 31, 2024 | $29.11M |
| Total Assets | Q2 2025 · Oct 31, 2024 | $71.05M |
| Total Assets | Q2 2025 · Apr 30, 2024 | $72.82M |
| Shares Diluted | Q2 2025 · Apr 30, 2024 | 10.5M sh |
| Shares Diluted | Q2 2025 · Apr 30, 2024 | 10.45M sh |
| Operating Cash Flow | Q2 2025 · Apr 30, 2024 | $1.04M |
| Stockholders Equity | Q2 2025 · Apr 30, 2024 | $34.61M |
| Stockholders Equity | Q2 2025 · Jan 31, 2024 | $38.66M |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | $39.76M |
| Eps Diluted | Q2 2025 · Apr 30, 2024 | −$0.41 |
| Eps Diluted | Q2 2025 · Apr 30, 2024 | −$0.54 |
| Eps Basic | Q2 2025 · Apr 30, 2024 | −$0.41 |
| Eps Basic | Q2 2025 · Apr 30, 2024 | −$0.54 |
| Sga Expense | Q2 2025 · Apr 30, 2024 | $4.6M |
| Sga Expense | Q2 2025 · Apr 30, 2024 | $9.22M |
| Rd Expense | Q2 2025 · Apr 30, 2024 | $637K |
| Rd Expense | Q2 2025 · Apr 30, 2024 | $1.41M |
| Net Income | Q2 2025 · Apr 30, 2024 | −$4.29M |
| Net Income | Q2 2025 · Apr 30, 2024 | −$5.66M |
| Operating Income | Q2 2025 · Apr 30, 2024 | −$415K |
| Operating Income | Q2 2025 · Apr 30, 2024 | −$2.5M |
| Gross Profit | Q2 2025 · Apr 30, 2024 | $4.82M |
| Gross Profit | Q2 2025 · Apr 30, 2024 | $8.13M |
| Cost Of Revenue | Q2 2025 · Apr 30, 2024 | $11.29M |
| Cost Of Revenue | Q2 2025 · Apr 30, 2024 | $21.44M |